Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Talazoparib with Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
Study Type: Treatment
Phase: III
NCTID: NCT03533582
Principal Investigator:
Keith August
Effectiveness of the SpaceOAR Vue System in Subjects with Prostate Cancer being Treated with Stereotactic Body Radiotherapy SABRE
Study Type: Prevention
Phase: N/A
NCTID: NCT04905069
Principal Investigator:
Ronald Chen
A Phase IIb Clinical Trial of the Multitargeted Recombinant Adenovirus 5 CEA/MUC1/Brachyury Vaccines Tri-Ad5 and IL-15 Superagonist N-803 in Lynch syndrome
The Cancer Tracking System CATSystem: A Randomized control trial to evaluate a systems level intervention for cervical cancer screening, treatment, referral and follow up in Kenya.
Study Type: Health Services
Phase: N/A
NCTID: NCT06286462
Principal Investigator:
Sarah Kessler
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Study Type: Treatment
Phase: III
NCTID: NCT02521493
Principal Investigator:
Keith August
A Phase I/II Study of Pembrolizumab MK-3475 in Children With Advanced Melanoma or a PD-L1 Positive Advanced, Relapsed or Refractory Solid Tumor or Lymphoma KEYNOTE-051
Study Type: Treatment
Phase: I/II
NCTID: NCT02332668
Principal Investigator:
Jaszianne Tolbert
A Phase IB/II Open-Label Trial of Tisotumab Vedotin HuMax-TF-ADC Monotherapy and in Combination with Other Agents in Subjects with Recurrent or Stage IVB Cervical Cancer
A Phase I/II Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation
Study Type: Treatment
Phase: I/II
NCTID: NCT03785249
Principal Investigator:
Jun Zhang
A Randomized Phase II Study of CHOEP vs CC-486- CHOEP vs duvelisib- CHOEP in previously Untreated CD30 Negative Peripheral T-cell Lymphomas
Study Type: Treatment
Phase: II
NCTID: NCT04803201
Principal Investigator:
Marc Hoffmann